| |
|
|
|
EuroSciCon, Cineworld: The O2, Peninsula Square, London,SE10 0DX, United Kingdom
Monday, 10 November 2014 09:00 - Wednesday, 12 November 2014 17:00
 A three day event discussing aspects of the innate immune system. This year there are three main topics for discussion - The Innate Immunity Interactions with Pathogens
- Interactions of the Innate and Adaptive Immune Systems
- Therapeutic applications of the Innate Immune system
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding an organisms first line of defense. This event has an open poster session. Posters can be submitted on any subject related to Innate Immunity. This event has CPD accreditation. The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Program Outline
Day 1: Innate Immunity Interactions with Pathogens
Infectious disease are still a major cause of morbidity and mortality worldwide. Innate immunity is of paramount importance for the control of pathogens in the early stages of the infection and for the engenderment and expansion of acquired immunity. This will be a premier forum for the presentation of cutting-edge research on how the interaction between innate immune mechanisms and pathogens impacts on host resistance, immunoevasion, immunodeficiencies and vaccine efficacy, providing a deep insight into future research and more rational measures to prevent and treat infectious diseases of humans and animals. Session Chair: Dr Pietro Mastroeni, Cambridge University, UK
The cells of the innate immune system play a crucial part in immune defense against disease but also respond to the presence of malignant cells, initiating and subsequently directing adaptive immune responses. The session will discuss the roles of different components of the innate immune system, with focus on disease mechanisms and interactions between inflammatory cells, antibodies and pathogenic or tumour antigens and how these impact on disease progression. The session will draw on new cutting edge research and will provide ample opportunity for networking and informal discussions. Session Chair: Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, UKDay 3: Therapeutic applications of the Innate Immune system
The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This session will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation. Session Chair: To be confirmedTalks Include:
Exploring pathogen recognition in innate immunity using Drosophila as a model host Is Immune Activation Necessary for HIV? Professor Wenzhe Ho, Dept. Pathology & Laboratory Medicine Dept. Anatomy & Cell Biology, Temple University School of Medicine, USA Non-specific Stressors: Under-appreciated Innate Defenses Dr Edmund LeGrand, Adjunct professor , Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA Dr Uzma Hasan, Oncoviruses and Innate Immunity Centre International de Recherche en Infectiologie, University Lyon, Hopital Lyon Sud, France Novel insights into the regulation of Toll-like receptor signalling Dr Sinead Miggin, Lecturer and Principal Investigator, National University of Ireland Maynooth, Ireland Purinergic signalling in controlling of intracellular parasites Soluble pattern recognition molecules and associated proteins – update on the lectin pathway of the complement system Professor Steffen Thiel, Department of Biomedicine, Aarhus University, Denmark Interaction of HIV with plasmacytoid dendritic cells and its relevance for HIV pathogenesis Dr Adriano Boasso, Principal Investigator - Research Fellow, Imperial College London, UK Lipid rafts influence NLR mediated immune responses against bacterial infections Novel Interactions between Fas and TLR signalling Dr Elizabeth Brint, Lecturer and Principal Investigator,University College Cork, Ireland Paramyxovirus Inhibition of Human Complement Pathways Professor Griffith Parks, Dept. of Microbiology and Immunology, Wake Forest School of Medicine, USA B- cells at the interface between innate and acquired immunity to bacterial pathogens Dr Pietro Mastroeni, Reader in Infection and Immunity, University of Cambridge, UK The MHC class II-associated invariant chain controls innate and adaptive immunity in B cells Dr Bénédicte Manoury, PI, DR2, CNRS, Hôpital Necker; Unité INSERM U1151, Paris, France Sepsis as a Model of Impaired Communication between the Innate and Adaptive Immune Systems Dr Jim Faix, Director of Chemistry & Immunology, Director of Point-of-Care Testing, Department of Pathology, Stanford University Medical Center, Stanford, USA B cells and tumours: novel insights into tumour-induced immune escape Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, UK Platelets as immune cells Dr Fabrice Cognasse, Senior Scientist, Deputy Director for Scientific Affairs, the Auvergne-Loire Regional Branch of the French National Blood System EFS, Etablissement Français du Sang Auvergne-Loire, France Intranasal vasoactive intestinal polypeptide (VIP) safely corrects multiple abnormalities in proteomics of innate immune responses and simultaneously restores regulation to differential genomic activation and suppression Dr Ritchie C. Shoemaker, Center for Research on Biotoxin Associated Illnesses, USA Regulation of autoimmune myocarditis andinflammatory cardiomyopathy by innate immunity High-intensity ultra-short electric pulse applications in modulating innate immunity Dr Sunil K. Joshi, Assistant Professor, Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA, USA Therapeutic Role of Probiotics in Inflammatory Joint Diseases Dr Vinod Singh, Associate Professor and Head, Department of Microbiology,Barkatullah University, Bhopal-462026(M.P), India M1/M2 Macrophages: A Copernican Revelation in Immunology Dr Charles Mills, BioMedical Consultants, United States
Keywords: Innate Immunity, DNA sensing, Inflammasome, Type I interferon, RLHs, TLRs, Interferon, rhinovirus, TLR4, rhinovirus, LPS, TLR, signal transduction, scaffold complexes, NLR, PRR, LPS, Salmonella, Innate Immunity, NLRP3, Inflammasome, IL1, infection, immunity TLRS, bacteria, Oxidants, TLRs, Bioinformatics and transcripome, TLR2, TLR5, ovine, bovine, evolution, inflammation, toll-like receptors, cytokines, pathogen, Toll-like receptor, ADAM15, 14-3-3, inflammation, cytokine, infection, immunity, pathogens, Plasmacytoid dendritic cells; HIV; interferon type I,, therapeutic, immunity, antibodies, B-cells, T-cells, TLR, autoimmunity, myocarditis, dendritic cells, inflammatory cardiomyopathy, Bioelectrics, Pulse Electric Field, Vaccination, Adjuvant, Dendritic cells, Probiotics,Immunomodulators,Antiinflammatory, Antiarthritis,Lactic acid bacilliLAB, Paramyxovirus, Innate Immunity, Fever, nutrients, stress, agent-based model, MHC II, Invariant chain, Toll-like receptors, B cells, inflammation; immune responses; immunomodulation; effector cells; cancer inflammation; cytokines; macrophages; NK cells, Platelet, innate immunity, Tranfsusion, danger signals, Lipid rafts, membranes, NLR proteins, Klebsiella pneumoniae, signaling
|
|
|
|
|
|
|
|
Organized by:
|
|
Euroscicon |
|
|
Invited Speakers:
|
|
Dr Pietro Mastroeni, Cambridge University, UK
Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, UK
Dr Petros Ligoxygakis, Lecturer of Genetics, University of Oxford, UK
Professor Wenzhe Ho, Dept. Pathology & Laboratory Medicine Dept. Anatomy & Cell Biology, Temple University School of Medicine, USA
Dr Edmund LeGrand, Adjunct professor , Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, TN, USA
Dr Uzma Hasan, Oncoviruses and Innate Immunity Centre International de Recherche en Infectiologie, University Lyon, Hopital Lyon Sud, France
Dr Sinead Miggin, Lecturer and Principal Investigator, National University of Ireland Maynooth, Ireland
Dr Robson Coutinho-Silva
Professor Steffen Thiel, Department of Biomedicine, Aarhus University, Denmark
Dr Adriano Boasso, Principal Investigator - Research Fellow, Imperial College London, UK
Dr Sanjay Batra, Assistant Professor, Louisiana State University, USA
Dr Elizabeth Brint, Lecturer and Principal Investigator,University College Cork, Ireland
Professor Griffith Parks, Dept. of Microbiology and Immunology, Wake Forest School of Medicine, USA
Dr Pietro Mastroeni, Reader in Infection and Immunity, University of Cambridge, UK
Dr Bénédicte Manoury, PI, DR2, CNRS, Hôpital Necker; Unité INSERM U1151, Paris, France
Dr Jim Faix, Director of Chemistry & Immunology, Director of Point-of-Care Testing, Department of Pathology, Stanford University Medical Center, Stanford, USA
Dr Sophia N. Karagiannis, Senior Lecturer in Translational Cancer Immunology, Head of Cancer Antibody Discovery and Immunotherapy, St John’s Institute of Dermatology, Division of Genetics and Molecular Medicine, King’s College London School of Medicine, UK
Dr Fabrice Cognasse, Senior Scientist, Deputy Director for Scientific Affairs, the Auvergne-Loire Regional Branch of the French National Blood System EFS, Etablissement Français du Sang Auvergne-Loire, France
Dr Ritchie C. Shoemaker, Center for Research on Biotoxin Associated Illnesses, USA
Dr Przemyslaw Blyszczuk, Junior Group Leader, Cardioimmunology, University of Zurich, Switzerland
Dr Sunil K. Joshi, Assistant Professor, Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA, USA
Dr Vinod Singh, Associate Professor and Head, Department of Microbiology,Barkatullah University, Bhopal-462026(M.P), India
Dr Charles Mills, BioMedical Consultants, United States
Dr Sema Becerik, Ege University, Turkey
Dr Claudia Monaco, Imperial College London, United Kingdom
Dr Hans U. Lutz, Institute of Biochemistry, Swiss Federal Institute of Technology, Switzerland
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
The deadline for abstract submissions for oral presentation is July 10th 2014.
|
|
|
|
|
|
|
|
Registration:
|
|
Click here to register
|
|
|
E-mail:
|
|
enquiries@euroscicon.com
|
|
|
|
|
|
|
|
|